ArticleMolecules (Basel, Switzerland)2026

Novel 2,4-Pyrimidinediamine Derivative as Potent EGFR Inhibitor for NSCLC Treatment.

Shiqi Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.